Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma × Postoperative Period × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Solid Tumor Spine Metastases 1 Sarcoma 1 Rectal Neoplasms 1 Oligodendroglioma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Lymphoma, Follicular 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Astrocytoma 1 Anxiety Disorders 1 Amenorrhea 1

Interventions

Doxorubicin 60 Radiotherapy 45 Ifosfamide 42 Gemcitabine 38 Cyclophosphamide 30 pazopanib 27 Docetaxel 25 pembrolizumab 23 Nivolumab 22 Filgrastim 22 Trabectedin 19 Etoposide 19 Surgical Procedures, Operative 18 Cisplatin 18 Blood Specimen Collection 16 Radiation 13 Carboplatin 13 Magnetic Resonance Spectroscopy 12 Ipilimumab 12 liposomal doxorubicin 11 Vincristine 11 Bevacizumab 11 apatinib 10 anlotinib 10 Temozolomide 10 Radiosurgery 10 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 Drug Therapy 10 Sorafenib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03896620 2025-12-24

Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma

Medical College of Wisconsin

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡